Open AccessComparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study
Author(s) -
Sandeep Gupta,
Vijay Khajuria,
Vishal R Tandon,
Annil Mahajan,
Zahid Gillani
Publication year - 2015
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.159942
Subject(s) - medicine , glimepiride , metformin , type 2 diabetes mellitus , hypoglycemia , adverse effect , diabetes mellitus , gastroenterology , endocrinology , body mass index , vildagliptin , randomized controlled trial , type 2 diabetes
The aim was to evaluate and compare the efficacy and safety of combinations of metformin-vidagliptin (MF-VG) and metfromin-glimepiride (MF-GP) in type 2 diabetes mellitus (T2DM) patients.